OnKure

Manufacturing · Colorado, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

6707 Winchester Cir Ste 400, Boulder, Co...

Phone Number

(720) 307-2892

Revenue

-

Stock Symbol

OKUR

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About OnKure

Onkure Therapeutics is a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapies for patients with cancer and serious diseases. Its research platform centers on identifying novel targets and advancing tailored treatments designed to address underlying biological mechanisms with high unmet medical need. Independent observers view Onkure as part of the evolving oncology and precision medicine landscape, bridging scientific discovery and clinical development in pursuit of therapies that may offer meaningful benefit where existing options are limited, while maintaining rigorous scientific evaluation and safety standards.Explore more
OnKure's Social MediaSIC Code 87,873NAICS Code 32,325Ticker NASDAQ: OKURShow more

OnKure Org Chart

Nicholas Saccomano, President & Chief Executive Officer at OnKure
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
DW
United States flag for contact location.

Chief Development Officer

PhoneEmail
Dylan Hartley, Chief Scientific Officer at OnKure
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
QZ
United States flag for contact location.

VP & Distinguished Fellow

PhoneEmail
JK
United States flag for contact location.

VP, Portfolio Strategy

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to OnKure

Compare insights from companies similar to OnKure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

OnKure

11-50
Public
$266M
2011
Nicholas Saccomano, President & Chief Executive Officer at OnKure
Nicholas SaccomanoPresident & CEO
<$5M
11-50
Private
$37.9M
2004
TM
Tadahiro MatsudairaVice President, Development
<$5M
11-50
Private
-
1998
TB
Terry BowlinPresident & CEO
<$5M
11-50
Private
-
1996
CB
Christoph BrueningIndependent Director
<$5M
11-50
Private
<$5M
2006
CC
Cassie CottrillChief of Staff
<$5M
11-50
Private
-
2010
Amitkumar Patel, Chief Operating Officer at AROG Pharmaceuticals
Amitkumar PatelChief Operating Officer
<$5M
11-50
Private
<$5M
2000
Illustration of an envelope

OnKure Tech Stack

A closer look at the technologies used by OnKure

Top Manufacturing Companies

Frequently Asked Questions Regarding OnKure

What is OnKure's stock symbol?
OnKure's stock symbol is OKUR
What is OnKure's official website?
OnKure's official website is www.onkuretherapeutics.com
What is OnKure's SIC code?
OnKure's SIC: 87,873
What is OnKure's NAICS code?
OnKure's NAICS: 32,325
How many employees does OnKure have?
OnKure has 11-50 employees
What industry does OnKure belong to?
OnKure is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is OnKure competition?
OnKure top competitors include: Bexion Pharmaceuticals, Callisto Pharmaceuticals, AROG Pharmaceuticals, NapaJen Pharma
What technology does OnKure use?
Some of the popular technologies that OnKure uses are: DocuSign, WordPress.org, PHP, Microsoft 365
How do I contact OnKure?
OnKure contact info: Phone number: (720) 307-2892 Website: www.onkuretherapeutics.com
What does OnKure do?

Onkure Therapeutics is a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapies for patients with cancer and serious diseases. Its research platform centers on identifying novel targets and advancing tailored treatments designed to address underlying biological mechanisms with high unmet medical need. Ind... ependent observers view Onkure as part of the evolving oncology and precision medicine landscape, bridging scientific discovery and clinical development in pursuit of therapies that may offer meaningful benefit where existing options are limited, while maintaining rigorous scientific evaluation and safety standards.Read More

What are OnKure social media links?
OnKure Linkedin page OnKure Twitter page
Who invested in OnKure?
OnKure has 11 investors including BlackRock, Cormorant Asset Management, Perceptive Advisors and Delian Capital.
Is OnKure a public company?
Yes, OnKure is a public company and is traded under the symbol OKUR
See more information about OnKure

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.